by AIP Online Bureau | Jan 27, 2022 | Health, Indian News, Pandemic, Policy
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting. Adverse event following immunisation will continue to be monitored New Delhi:India’s drug regulator on Thursday granted regular...
by AIP Online Bureau | Jan 26, 2022 | Eco/Invest/Demography, Health, Indian News, Pandemic, Policy
As of now, Covaxin is priced at Rs 1,200 per dose while Covishield costs Rs 780 in private facilities. The prices include Rs 150 service charge. Both the vaccines are only authorised for emergency use in the country New Delhi: The price of Covishield and Covaxin, the...
by AIP Online Bureau | Jan 20, 2022 | Health, Indian News, Pandemic, Policy, Regulation
“The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) which reviewed SII and Bharat Biotech’s application for the second time on Wednesday has recommended granting regular market approval to Covishield...
by AIP Online Bureau | Nov 9, 2021 | Health, Indian News, Pandemic, Workplace/Employee Benefits
Among 96 nations include Canada, the United States of America, Australia, Spain, the United Kingdom, France, Germany, Belgium, Russia, and Switzerland. New Delhi: As many as 96 countries have recognised Covaxin and Covishield and both of these COVID-19 vaccines have...
